{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:57:13Z","timestamp":1782017833512,"version":"3.54.5"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0238089","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T13:22:34Z","timestamp":1599657754000},"page":"e0238089","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma"],"prefix":"10.1371","volume":"15","author":[{"given":"Lluc","family":"Farrera-Soler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Daguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3830-1178","authenticated-orcid":true,"given":"Sofia","family":"Barluenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3511-6479","authenticated-orcid":true,"given":"Oscar","family":"Vadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Yerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Vuilleumier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1636-7766","authenticated-orcid":true,"given":"Nicolas","family":"Winssinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"issue":"6475","key":"pone.0238089.ref001","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1126\/science.367.6475.234","article-title":"New SARS-like virus in China triggers alarm","volume":"367","author":"J Cohen","year":"2020","journal-title":"Science"},{"key":"pone.0238089.ref002","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","article-title":"The socio-economic implications of the coronavirus pandemic (COVID-19): A review","volume":"78","author":"M Nicola","year":"2020","journal-title":"International Journal of Surgery"},{"issue":"12","key":"pone.0238089.ref003","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1002\/j.1460-2075.1985.tb04086.x","article-title":"Priming immunization against cholera toxin and E. coli heat-labile toxin by a cholera toxin short peptide-beta-galactosidase hybrid synthesized in E. coli","volume":"4","author":"CO Jacob","year":"1985","journal-title":"EMBO J"},{"key":"pone.0238089.ref004","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.trivac.2016.04.003","article-title":"B-cell epitope mapping for the design of vaccines and effective diagnostics","volume":"5","author":"TA Ahmad","year":"2016","journal-title":"Trials in Vaccinology"},{"issue":"2","key":"pone.0238089.ref005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-3542(00)00111-X","article-title":"Antibodies for the prevention and treatment of viral diseases","volume":"47","author":"LA Sawyer","year":"2000","journal-title":"Antiviral Res"},{"issue":"9","key":"pone.0238089.ref006","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1128\/JVI.78.9.4552-4560.2004","article-title":"Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor","volume":"78","author":"GJ Babcock","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"pone.0238089.ref007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4161\/mabs.2.1.10788","article-title":"Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology","volume":"2","author":"JD Berry","year":"2010","journal-title":"MAbs"},{"issue":"2","key":"pone.0238089.ref008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.virol.2004.04.017","article-title":"SARS corona virus peptides recognized by antibodies in the sera of convalescent cases","volume":"324","author":"JP Guo","year":"2004","journal-title":"Virology"},{"issue":"6","key":"pone.0238089.ref009","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.4049\/jimmunol.173.6.4050","article-title":"Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines","volume":"173","author":"Y He","year":"2004","journal-title":"J Immunol"},{"issue":"13","key":"pone.0238089.ref010","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1128\/JVI.78.13.7217-7226.2004","article-title":"An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies","volume":"78","author":"T Zhou","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"pone.0238089.ref011","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2005.01.035","article-title":"Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)","volume":"334","author":"TH Chou","year":"2005","journal-title":"Virology"},{"issue":"3","key":"pone.0238089.ref012","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1128\/JVI.79.3.1635-1644.2005","article-title":"Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus","volume":"79","author":"EN van den Brink","year":"2005","journal-title":"J Virol"},{"issue":"6","key":"pone.0238089.ref013","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1128\/JVI.79.6.3401-3408.2005","article-title":"B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein","volume":"79","author":"X Zhong","year":"2005","journal-title":"J Virol"},{"issue":"5","key":"pone.0238089.ref014","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/acsinfecdis.6b00006","article-title":"Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates","volume":"2","author":"Q Wang","year":"2016","journal-title":"ACS Infect Dis"},{"key":"pone.0238089.ref015","author":"K. Garber","year":"2020","journal-title":"Coronavirus vaccine developers wary of errant antibodies"},{"issue":"5","key":"pone.0238089.ref016","article-title":"Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry","volume":"94","author":"Y Wan","year":"2020","journal-title":"J Virol"},{"issue":"6494","key":"pone.0238089.ref017","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"BS Graham","year":"2020","journal-title":"Science"},{"key":"pone.0238089.ref018","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","author":"D Pinto","year":"2020","journal-title":"Nature"},{"issue":"1","key":"pone.0238089.ref019","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/s41467-020-16256-y","article-title":"A human monoclonal antibody blocking SARS-CoV-2 infection","volume":"11","author":"C Wang","year":"2020","journal-title":"Nat Commun"},{"key":"pone.0238089.ref020","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells","author":"Y Cao","year":"2020","journal-title":"Cell"},{"key":"pone.0238089.ref021","article-title":"Identification of Human Single-Domain Antibodies against SARS-CoV-2","author":"Y Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"pone.0238089.ref022","first-page":"091298","article-title":"Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual","author":"E Seydoux","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref023","article-title":"A human neutralizing antibody targets the receptor binding site of SARS-CoV-2","author":"R Shi","year":"2020","journal-title":"Nature"},{"key":"pone.0238089.ref024","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","author":"Y Wu","year":"2020","journal-title":"Science"},{"key":"pone.0238089.ref025","article-title":"A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV","author":"M Yuan","year":"2020","journal-title":"Science"},{"key":"pone.0238089.ref026","first-page":"074930","article-title":"Design of an Epitope-Based Peptide Vaccine against the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): A Vaccine Informatics Approach","author":"A Khan","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref027","article-title":"Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach","author":"M Bhattacharya","year":"2020","journal-title":"J Med Virol"},{"key":"pone.0238089.ref028","first-page":"055467","article-title":"Multi-epitope based peptide vaccine design against SARS-CoV-2 using its spike protein","author":"D Mitra","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref029","first-page":"955484","article-title":"Potential T-cell and B-cell Epitopes of 2019-nCoV","author":"E Fast","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref030","first-page":"095885","article-title":"Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2","author":"A Gao","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref031","author":"S Parvez","year":"2020","journal-title":"Prediction of T and B Cell Epitopes in the Proteome of SARS-CoV-2 for Potential Use in Diagnostics and Vaccine Design"},{"key":"pone.0238089.ref032","first-page":"965434","article-title":"Epitope-based peptide vaccine design and target site characterization against novel coronavirus disease caused by SARS-CoV-2","author":"L Li","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref033","first-page":"095133","article-title":"Identification of conserved epitopes in SARS-CoV-2 spike and nucleocapsid protein","author":"S Forcelloni","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref034","article-title":"Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV","author":"M Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"pone.0238089.ref035","doi-asserted-by":"crossref","DOI":"10.3390\/v12030254","article-title":"Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies","volume":"12","author":"SF Ahmed","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"pone.0238089.ref036","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2","volume":"27","author":"A Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"pone.0238089.ref037","first-page":"056853","article-title":"Mapping the Immunodominance Landscape of SARS-CoV-2 Spike Protein for the Design of Vaccines against COVID-19","author":"B-z Zhang","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref038","first-page":"994756","article-title":"SARS-CoV-2 proteome microarray for mapping COVID-19 antibody interactions at amino acid resolution","author":"H Wang","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref039","first-page":"015461","article-title":"Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein","author":"CM Poh","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref040","first-page":"109298","article-title":"Recombinant SARS-CoV-2 spike proteins for sero-surveillance and epitope mapping","author":"SM Jegouic","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref041","first-page":"20039495","article-title":"Global profiling of SARS-CoV-2 specific IgG\/ IgM responses of convalescents using a proteome microarray","author":"H-w Jiang","year":"2020","journal-title":"medRxiv"},{"key":"pone.0238089.ref042","first-page":"20085068","article-title":"Antibody Profiling and Prevalence in the US population during the SARS-CoV2 Pandemic","author":"HK Krishnamurthy","year":"2020","journal-title":"medRxiv"},{"key":"pone.0238089.ref043","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study","author":"S Stringhini","journal-title":"The Lancet"},{"key":"pone.0238089.ref044","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cbpa.2015.01.005","article-title":"PNA-encoded chemical libraries","volume":"26","author":"C Zambaldo","year":"2015","journal-title":"Curr Opin Chem Biol"},{"issue":"40","key":"pone.0238089.ref045","doi-asserted-by":"crossref","first-page":"12698","DOI":"10.1002\/chem.201201337","article-title":"Expanding the Scope of PNA-Encoded Synthesis (PES): Mtt-Protected PNA Fully Orthogonal to Fmoc Chemistry and a Broad Array of Robust Diversity-Generating Reactions","volume":"18","author":"D Chouikhi","year":"2012","journal-title":"Chem-Eur J"},{"issue":"W1","key":"pone.0238089.ref046","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"F Madeira","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"7798","key":"pone.0238089.ref047","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"F Wu","year":"2020","journal-title":"Nature"},{"issue":"10224","key":"pone.0238089.ref048","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"R Lu","year":"2020","journal-title":"Lancet"},{"issue":"7798","key":"pone.0238089.ref049","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"P Zhou","year":"2020","journal-title":"Nature"},{"issue":"2","key":"pone.0238089.ref050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"M Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"6485","key":"pone.0238089.ref051","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"R Yan","year":"2020","journal-title":"Science"},{"issue":"23","key":"pone.0238089.ref052","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.1002\/chem.200500305","article-title":"PNA encoding (PNA = peptide nucleic acid): From solution-based libraries to organized microarrays","volume":"11","author":"JL Harris","year":"2005","journal-title":"Chem-Eur J"},{"issue":"2","key":"pone.0238089.ref053","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"AC Walls","year":"2020","journal-title":"Cell"},{"issue":"6483","key":"pone.0238089.ref054","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"D Wrapp","year":"2020","journal-title":"Science"},{"issue":"21","key":"pone.0238089.ref055","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"J Shang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0238089.ref056","first-page":"22","article-title":"Profile of a killer virus","volume":"581","author":"D. Cyranoski","year":"2020","journal-title":"Nature"},{"key":"pone.0238089.ref057","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"B Coutard","year":"2020","journal-title":"Antiviral Res"},{"key":"pone.0238089.ref058","article-title":"A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility","author":"Q Wang","year":"2020","journal-title":"Virol Sin"},{"key":"pone.0238089.ref059","first-page":"926006","article-title":"The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS","author":"T Meng","year":"2020","journal-title":"bioRxiv"},{"issue":"10","key":"pone.0238089.ref060","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1016\/j.jmb.2020.04.009","article-title":"Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop","volume":"432","author":"JA Jaimes","year":"2020","journal-title":"J Mol Biol"},{"key":"pone.0238089.ref061","doi-asserted-by":"crossref","first-page":"104792","DOI":"10.1016\/j.antiviral.2020.104792","article-title":"Coronavirus membrane fusion mechanism offers a potential target for antiviral development","volume":"178","author":"T Tang","year":"2020","journal-title":"Antiviral Research"},{"issue":"5","key":"pone.0238089.ref062","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01774-19","article-title":"Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection","volume":"94","author":"VD Menachery","year":"2020","journal-title":"J Virol"},{"issue":"1","key":"pone.0238089.ref063","doi-asserted-by":"crossref","first-page":"11518","DOI":"10.1038\/s41598-018-29944-z","article-title":"Evolution of high pathogenicity of H5 avian influenza virus: haemagglutinin cleavage site selection of reverse-genetics mutants during passage in chickens","volume":"8","author":"JM Luczo","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0238089.ref064","article-title":"SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects","author":"AG Wrobel","year":"2020","journal-title":"Nature Structural & Molecular Biology"},{"key":"pone.0238089.ref065","first-page":"929042","article-title":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells","author":"M Hoffmann","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0238089.ref066","first-page":"009233","article-title":"Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity","author":"Y Zhu","year":"2020","journal-title":"bioRxiv"},{"issue":"15","key":"pone.0238089.ref067","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.1128\/JVI.00079-09","article-title":"Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide","volume":"83","author":"IG Madu","year":"2009","journal-title":"J Virol"},{"issue":"9","key":"pone.0238089.ref068","article-title":"A Fusion Peptide in the Spike Protein of MERS Coronavirus","volume":"11","author":"EAJ Alsaadi","year":"2019","journal-title":"Viruses"},{"issue":"4","key":"pone.0238089.ref069","doi-asserted-by":"crossref","first-page":"eaav4580","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"S Xia","year":"2019","journal-title":"Sci Adv"},{"issue":"11","key":"pone.0238089.ref070","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/infdis\/jir084","article-title":"Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model","volume":"203","author":"T Miyoshi-Akiyama","year":"2011","journal-title":"J Infect Dis"},{"key":"pone.0238089.ref071","first-page":"084103","article-title":"AI334 and AQ806 antibodies recognize the spike S protein from SARS-CoV-2 by ELISA","author":"P Hammel","year":"2020","journal-title":"bioRxiv"},{"issue":"6501","key":"pone.0238089.ref072","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Y Watanabe","year":"2020","journal-title":"Science"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T08:55:41Z","timestamp":1668675341000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238089"}},"subtitle":[],"editor":[{"given":"Nicholas J.","family":"Mantis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":72,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238089","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.15.20131391","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,9]]}}}